Reading mode Exit reading mode

COVID Misinformation: Hydroxychloroquine, Bleach Injection, UV Light Promotion

Trump promoted hydroxychloroquine at least 65 times in White House briefings before studies established it was ineffective and potentially dangerous for COVID. He suggested at an April 23, 2020 briefing that injecting disinfectants might work as treatment and asked officials to study inserting UV light 'inside the body.' Poison control centers reported a spike in calls after the disinfectant comments. The FDA granted hydroxychloroquine an Emergency Use Authorization in March 2020 under White House pressure, then revoked it in June 2020 citing 'serious cardiac adverse events.' Trump campaign donors funded oleander extract studies. His false '35% mortality improvement' claim for convalescent plasma prompted FDA Commissioner Stephen Hahn to issue a correction the same day.

Record summary

Grade

Grade 4 of 5: Critical Rights and Rule-of-Law Concern

Systematic actions that undermine fundamental constitutional or international legal protections at the structural level. Scale and definitions

Status
Concluded
Incident date
Record updated
Location
Washington, D.C.
Category
Rule of Law
Legal posture
Reported
War-crime classification
Enabling conduct
Verification
Independently verified
ICC relevance
No
Sources
4 cited
Stable ID
trump-hydroxychloroquine-bleach-covid-misinformation
Victims
Americans who took hydroxychloroquine without clinical indication based on presidential promotion; cardiac patients whose hydroxychloroquine supplies were disrupted; people who ingested disinfectants following the briefing comments; public health credibility damaged during critical pandemic period
Alleged responsible parties
  • Donald Trump, President; repeatedly promoted unproven treatments from White House podium; pressured FDA to grant hydroxychloroquine EUA— White House

Key points

  • Trump promoted hydroxychloroquine at White House briefings at least 65 times before the drug's limitations for COVID were established; the drug had known serious cardiac risks; the FDA granted an Emergency Use Authorization in March 2020 under White House pressure and revoked it in June 2020
  • At an April 23, 2020 White House briefing, Trump suggested aloud: 'I see the disinfectant that knocks it out in a minute... is there a way we can do something like that, by injection inside, or almost a cleaning?' Lysol and Dettol both issued statements warning people not to ingest their products; poison control centers reported a national spike in disinfectant-related calls in the 24 hours following
  • At the same April 23 briefing, Trump asked officials to study whether ultraviolet light could work 'inside the body' to kill the virus; Trump later claimed he was being 'sarcastic' — the video of the briefing shows no indication of sarcasm
  • Trump promoted oleander extract (trademarked as 'Oleandrin') as a COVID treatment; the supplement had no clinical trial data for COVID and was promoted by MyPillow CEO Mike Lindell, a Trump campaign donor; FDA officials declined to grant it an EUA
  • When the FDA granted an Emergency Use Authorization for convalescent plasma on August 23, 2020, Trump claimed it showed '35 percent improvement in mortality'; FDA Commissioner Stephen Hahn stated on the same day that the figure was incorrect and the actual data showed a different (lower) benefit; Hahn later said he had 'made an error'
  • Trump publicly attacked his own FDA in tweets for moving 'too slowly' on vaccine and treatment approvals, and his chief of staff Mark Meadows pressured FDA officials; the FDA's career staff later described White House interference in their regulatory process

Overview

The White House podium during the COVID pandemic became a venue for promoting treatments that ranged from unproven (hydroxychloroquine, convalescent plasma) to dangerous (bleach injection, UV light inside the body). The president's stated rationale was hope: "What do you have to lose?"

The answer was: cardiac arrhythmia, chemical burns, and a disrupted supply chain for drugs that immunocompromised patients actually needed.

Hydroxychloroquine

Trump promoted hydroxychloroquine at White House briefings at least 65 times. The drug had established uses for lupus and rheumatoid arthritis; it also had known cardiac side effects. The FDA granted an Emergency Use Authorization in March 2020 under White House pressure, before clinical trials could establish efficacy or safety for COVID.

The trials established neither. Multiple randomized controlled trials found no benefit. The FDA revoked the EUA in June 2020 citing cardiac risk. The disruption to lupus patients' access to their medication was documented.

The Disinfectant Briefing

On April 23, 2020, the President of the United States stood before cameras and mused aloud about injecting disinfectants as a COVID treatment. He turned to the officials beside him — the director of the DHS Science and Technology Directorate — and asked whether they could look into it.

Lysol and Dettol issued public statements. Poison control centers documented a national spike in calls. Trump claimed he had been sarcastic. The video showed no indication of sarcasm.

The FDA Pressure Pattern

The hydroxychloroquine EUA, the convalescent plasma approval, and the public attacks on FDA "slowness" documented a pattern: the White House treated the FDA as a communications vehicle for good news rather than a scientific regulator. When the FDA's data did not support the message Trump wanted to deliver, he delivered a different message and left his own FDA Commissioner to issue corrections.

Update log

  1. Updated with convalescent plasma EUA incident.

Sequence of events

  1. Trump begins hydroxychloroquine promotion

    Trump publicly promotes hydroxychloroquine as a potential COVID treatment at a White House briefing, before any clinical trial results. He will promote it at least 65 more times.

  2. FDA grants hydroxychloroquine Emergency Use Authorization

    The FDA grants an Emergency Use Authorization for hydroxychloroquine for hospitalized COVID patients under White House pressure. Supplies for lupus and rheumatoid arthritis patients — the drug's established uses — become disrupted.

  3. Trump suggests bleach injection and UV light 'inside the body'

    At a White House briefing, Trump suggests injection of disinfectants and UV light inside the body as potential COVID treatments. Poison control centers report a spike in disinfectant calls. Manufacturers issue warnings. Trump claims sarcasm.

  4. FDA revokes hydroxychloroquine EUA

    The FDA revokes its Emergency Use Authorization for hydroxychloroquine, citing evidence the drug is 'unlikely to be effective' for COVID and poses serious cardiac risks. Multiple randomized controlled trials have found no benefit.

  5. Trump claims '35% mortality improvement' for convalescent plasma — FDA corrects him

    Trump overstates the convalescent plasma data at an EUA announcement. FDA Commissioner Hahn contradicts the '35%' figure the same day and issues a correction. The incident draws criticism about White House pressure on the FDA's scientific communications.

Sources

  1. Trump Muses About Light and Disinfectant as Virus Cures — The New York Times
  2. FDA revokes authorization for hydroxychloroquine as a COVID-19 treatment — The Washington Post
  3. Calls to poison control spiked after Trump's disinfectant comments — The Associated Press
  4. Trump Pressured FDA Over Convalescent Plasma as Hahn Corrected False Claim — The New York Times

How this record was published

Manually curated This entry was added directly and does not carry an automated audit trail.

About our editorial methodology →

Related records

Similar by category, grade and tags.

  • Grade 4 of 5: Critical Rights and Rule-of-Law Concern

    COVID-19 Downplaying: Woodward Tapes Reveal Trump Knew and Lied

    Trump told Woodward on February 7, 2020 that COVID-19 was 'deadly stuff' and acknowledged it was much more dangerous than the flu. On the same days he was giving Woodward these assessments, Trump was telling the public the virus was 'like the flu' and 'will disappear.' On March 19, 2020, Trump told Woodward: 'I wanted to always play it down. I still like playing it down, because I don't like to panic people.' The Woodward recordings also captured Trump describing COVID's airborne transmission weeks before public health officials acknowledged it. The U.S. death toll reached 200,000 by September 2020 when the recordings were published.

  • Grade 4 of 5: Critical Rights and Rule-of-Law Concern

    Scott Atlas and Herd Immunity: Trump's COVID Advisor Who Contradicted Scientists

    Atlas was a Hoover Institution senior fellow and media commentator with no relevant credentials for pandemic response. Trump appointed him after seeing him on Fox News. Atlas advocated the Great Barrington Declaration approach — allowing the virus to spread among the young and healthy while 'protecting' the vulnerable. Public health experts pointed out this approach was not operationally feasible and would require accepting enormous numbers of preventable deaths. CDC Director Robert Redfield and the Coronavirus Task Force's other scientific advisors repeatedly contradicted Atlas. Deborah Birx described Atlas in her memoir as actively harmful to the pandemic response.

  • Grade 4 of 5: Critical Rights and Rule-of-Law Concern

    CDC and FDA Political Interference: Science Overridden for Political Messaging

    The Washington Post and New York Times documented a pattern of White House interference with CDC scientific publications. CDC reports in the MMWR — the agency's flagship peer-reviewed publication that had never previously been subject to political review — were reviewed and in some cases altered by Michael Caputo, a political appointee installed at HHS with no public health credentials. Caputo was later placed on leave after a Facebook video in which he accused CDC scientists of a 'resistance unit' against Trump. CDC Director Redfield testified that CDC school reopening guidance was replaced after Trump tweeted that it was 'very tough and expensive.' The FDA's hydroxychloroquine EUA and convalescent plasma approval were both accompanied by documented political pressure.

  • Grade 4 of 5: Critical Rights and Rule-of-Law Concern

    Opioid Crisis: Declared Emergency Without Funding, Commission Recommendations Ignored

    The Christie Commission had explicitly recommended declaring a national emergency under the Stafford Act or the Public Health Service Act, which would have freed up billions in emergency funding and allowed waiver of normal bureaucratic requirements. Trump instead declared a 'public health emergency' under a different statute (the Public Health Service Act § 319), which allowed no new money unless Congress appropriated it. Congress had not appropriated it. The declaration was described by public health experts as largely symbolic. Drug overdose deaths continued to rise throughout Trump's term.